Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-28 02:31:35 - browse：28695

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： The Harvard botanist who searched for psychedelics in the Amazon

focus

WSS

Heart disease and mental health: A look at cardiac psychology

He's a Nobel laureate. Critics say he was misleading on Covid

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Obesity drugs seen as possible treatment for liver disease MASH

New menopause drug shows promise in relief for hot flashes

A new nitrogen execution bill also undermines medical licensing

knowledge

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Hollywood unions extend contract negotiations for actors

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Tori Bowie and the unacceptable rates of Black maternal death

A solution to the after

Walensky prepares to leave CDC — and Congress — behind

Risky weight loss products often used by teens globally, per study

Guidelines to prevent youth baseball injuries need more muscle

Why palliative psychiatry is worth discussing

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The SUPPORT Act is critical to fighting the opioid crisis

focus

Caregivers of transplant patients call for more support, training

HHS names first

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

DeSantis can now import cheaper drugs. But will Biden get credit?

DeSantis can now import cheaper drugs. But will Biden get credit?

PBM reform efforts get punted in Congress

knowledge

focus

focus

hotspot